“Novel Cancer Diagnostic Earns Hao a PhRMA Grant”

The Hao Lab has been awarded a Faculty Starter Grant in Translational Medicine from the Pharmaceutical Research and Manufacturers of America (PhRMA) Foundation, which will support research to develop diagnostic tools to predict treatment efficacy of bispecific T cell engager (BiTE) antibodies.